Business

Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance

NEW YORK, July 22, 2025--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data ("2Q Risk Adjustment

articleOscar Health, Inc.July 22, 202510/company/oscar-health-inc/news/oscar-health-announces-preliminary-financial-100000097
Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance

About this update from Oscar Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/8a689af088b91af5c6a6c5cf0453ea9b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cmFFrd3ZtolvEWypecwTlA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8a689af088b91af5c6a6c5cf0453ea9b","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Bwn0LNgVaaG.09AYL9CHIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/8a689af088b91af5c6a6c5cf0453ea9b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEW YORK, July 22, 2025--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data ("2Q Risk Adjustment Reports") from Wakely, an independent actuarial firm, that analyzes paid claims submissions through April 30, 2025 for most Marketplace insurance carriers.","length":703,"tagName":"p"},{"type":"text","content":""The individual market is a competitive healthcare marketplace that provides affordable, high-quality coverage for millions of consumers across the country," said Mark Bertolini, CEO of Oscar Health. "We are taking appropriate pricing actions for 2026 that reflect higher acuity in the individual market, and we will continue to take steps to deliver for our members, partners, and shareholders. Oscar has successfully navigated dynamic markets before and we remain committed to our long-term strategy to bring more employees, individuals, and families healthcare choices that fit their needs through the individual market."","length":644,"tagName":"p"},{"type":"text","content":"The analysis of the 2Q Risk Adjustment Reports, covering nearly 100% of Oscar’s geographic footprint, shows that overall ACA Marketplace risk scores, a measure of the ...

More updates from Oscar Health, Inc.

The CompanyOscar Healthmedical loss ratioExpense RatioRisk AdjustmentTotal RevenueACA Marketplacefinancial resultspreliminary results